Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 582
Selected: 0
NCT IDTitle
NCT03043989Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin
NCT00796562Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy
NCT02485990Study of Tremelimumab Alone or Combined With Olaparib for Patients With Persistent EOC (Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma)
NCT00524017Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract
NCT02396368A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer
NCT03542604Cancer, Obesity/Overweight and Insomnia Study
NCT02738866Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor
NCT05121545Proton Pencil Beam Scanning GRID for Treatment of Bulky Tumors
NCT00770471ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT02405819Patient and Provider Initiated Survivorship Care Planning
NCT00369681Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma
NCT00249847Study of PET Scans and Serotonin in Hot Flashes Treatment
NCT00006358Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor
NCT01282216Patient-donor Vaccination in the Context of Allogeneic Bone Marrow Transplant With Post-transplant Cyclophosphamide
NCT00276601Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia
NCT03886493Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer
NCT04589247Improving Cancer On-treatment Symptom Management
NCT03914742BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations
NCT00348088Melanoma Biomarker Study
NCT00003176Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma
NCT00390403Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT01700673Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS
NCT00558948Musculoskeletal Outcomes After Bone Marrow Transplant
NCT07209189Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
NCT00478062Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma
NCT05658731Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
NCT01293539Intra-arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma
NCT03603002Pathologic and Immunologic Response After Ablative Radiation in Lung Cancer
NCT05585684Liquid Biopsy-informed Precision Oncology Study to Evaluate Utility of Plasma Genomic Profiling for Therapy Selection
NCT05025423Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell Lymphoma
NCT00047242UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors
NCT01763970Stereotactic Radiation Therapy for Pediatric Sarcomas
NCT00358397One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy
NCT01502605Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomas
NCT03707457Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma
NCT05823571Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients
NCT06617923Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
NCT00946023Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab
NCT00895180Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme
NCT04209686Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma
NCT00399529Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer
NCT04117087Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected Mismatch Repair Protein (MMR-p) Colorectal and Pancreatic Cancer
NCT00003561Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
NCT01876511Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors (Cohorts A, B and C)
NCT02716948SRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or Spine
NCT05995821Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
NCT02722616Ultrasound Monitoring of Abdominal Soft Tissue
NCT03554317COMbination of Bipolar Androgen Therapy and Nivolumab
NCT04188678Resiliency in Older Adults Undergoing Bone Marrow Transplant
NCT07071155Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia